ClinicalTrials.Veeva

Menu

Genetics of Schizophrenia

S

Sheba Medical Center

Status

Unknown

Conditions

Schizophrenia

Study type

Observational

Funder types

Other

Identifiers

NCT00619437
SHEBA-07-4620-RG-CTIL

Details and patient eligibility

About

Genetic etiology in schizophrenia is widely accepted. However, many chromosomal sites were shown to characterize the families of patients with schizophrenia. This is probably due to the high genetic heterogenity of this illness. Thus, it is important to investigate the genetic factor in relatively genetically homogenous populations. Many studies have indicate that Ashkenazy Jews show relative gentic homogenity. Indeed, the genes responsible for most Mendelian disorders of Jewish peoples have been identified. The study will apply genome-wide mutation screening methods to identify candidate allells in subjects of Ashkenazi Jewish ancestry with multiplex schizophrenia.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 78 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age 18+;
  2. Meet DSM-IV criteria for Schizophrenia;
  3. At least one first-degree relative who Meet DSM-IV criteria for Schizophrenia;
  4. Can sign the informed consent form.

Exclusion criteria

  1. Patients suffering from terminal or incurabale disease;
  2. Minors, incompetents

Trial contacts and locations

1

Loading...

Central trial contact

Raz Gross, MD, MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems